REGN vs MSFT: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Microsoft Corp in 2026
REGN
Regeneron Pharmaceuticals Inc
$781.67
MSFT
Microsoft Corp
$397.23
Key Metrics Comparison
| Metric | REGN | MSFT | Winner |
|---|---|---|---|
| Market Cap | $82.64B | N/A | REGN |
| P/E Ratio | 18.83 | 36.30 | REGN |
| EPS (TTM) | $41.51 | $13.70 | REGN |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 44.6% | 68.8% | MSFT |
Analyze REGN
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or MSFT a better investment?
Comparing REGN and MSFT: Regeneron Pharmaceuticals Inc has a market cap of $82.64B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and MSFT?
REGN (Regeneron Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or MSFT?
Based on P/E ratios, REGN trades at a lower multiple (18.8x vs 36.3x).
Which is growing faster: REGN or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for REGN.
Which company is more profitable: REGN or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 44.6% for REGN.
Which is the larger company: REGN or MSFT?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $82.64B compared to N/A for MSFT.
Should I buy REGN or MSFT in 2026?
Both REGN and MSFT have investment merit. REGN trades at $781.67 while MSFT trades at $397.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and MSFT stock?
Key differences: Market Cap ($82.64B vs N/A), P/E Ratio (18.8x vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (44.6% vs 68.8%).